LSD molecule:

Image from PubChem

LSD Clinical Trials

Safety and efficacy of low dose lysergic acid diethylamide (LSD) as treatment for ADHD in adults: a multicentre, randomized, double- blind, placebo-controlled Phase 2a Proof of Concept Trial

To see complete record on, please visit this link

Id: 2020-001098-55

Organisation Name: Mind Medicine, Inc.

Start Date: 2020-05-18

Completion Date: Ongoing

Brief Summary: To assess the response as measured by Adult Attention Deficit Investigator Symptom Rating Scale (AISRS) to treatment with repeated low doses (20 mcg) of lysergic acid diethylamide (LSD) for six weeks in adult patients with ADHD.

Country: Netherlands

Total execution time in seconds: 0.18144202232361